vimarsana.com
Home
Live Updates
Breakthrough in Device Therapy for Patients with Late-Stage
Breakthrough in Device Therapy for Patients with Late-Stage
Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease
/PRNewswire/ -- Severe heart failure is the most life-threatening medical condition in all age groups across the globe. Implantable heart pumps, known as...
Related Keywords
Czech Republic ,
Leuven ,
Region Flamande ,
Belgium ,
Prague ,
Praha ,
Hlavníesto ,
Newcastle Upon Tyne ,
United Kingdom ,
Israel ,
Ivan Netuka ,
Michael Zilbershlag ,
Calon Mini ,
Calon Cardiomini ,
Stuart Mcconchie ,
Stephen Westaby ,
Stephan Schueler ,
Marc Clement ,
Centre Of Excellence ,
Cardio Ltd ,
Technology Ltd ,
Development Bank ,
Catholic University Of Leuven ,
Institute For Clinical ,
Israel Innovation Authority ,
Head Of Department Cardiothoracic Surgery ,
Trendlines Group ,
United Kingdom Future Fund ,
Ventricular Assist Devices ,
Catholic University ,
Calon Cardio Technology Ltd ,
Leviticus Cardioltd ,
Professor Ivan Netuka ,
Cardiac Surgeon ,
Experimental Medicine ,
Calon Cardio ,
Leviticus Cardio ,
Professor Stephan Schueler ,
Cardiothoracic Surgery ,
Newcastle Upon Tyne Hospitals ,
Professor Stephen Westaby ,
Professor Marc Clement ,
United Kingdom Government Grants ,
Longbow Capital ,
Breakthrough Device Designation ,
Calon Cardio Technology ,
Cardio Technology Ltd ,
Calon Cardio Technology Ltd Leviticus ,